Real-time enrollment status for this gastroenteropancreatic neuroendocrine tumor clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 12:46 AM UTC
| NCT Number | NCT07635316 |
| Recruiting Status | Recruiting |
| Condition | Gastroenteropancreatic Neuroendocrine Tumor |
| Phase | Clinical Trial |
| Target Enrollment | 4,023 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 15, 2026 (4 days ago) |
As of October 19, 2026: Clinical trial NCT07635316 is currently recruiting participants. This clinical trial study for gastroenteropancreatic neuroendocrine tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07635316 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07635316 was last updated 4 days ago (October 15, 2026). HelloStudys verifies this status automatically.